Evidence of Enhanced Iron Excretion During Systemic Phosphorothioate Oligodeoxynucleotide Treatment

Article Properties
Cite
Mata, John E., et al. “Evidence of Enhanced Iron Excretion During Systemic Phosphorothioate Oligodeoxynucleotide Treatment”. Journal of Toxicology: Clinical Toxicology, vol. 38, no. 4, 2000, pp. 383-7, https://doi.org/10.1081/clt-100100947.
Mata, J. E., Bishop, M. R., Tarantolo, S. R., Angle, C. R., Swanson, S. A., & Iversen, P. L. (2000). Evidence of Enhanced Iron Excretion During Systemic Phosphorothioate Oligodeoxynucleotide Treatment. Journal of Toxicology: Clinical Toxicology, 38(4), 383-387. https://doi.org/10.1081/clt-100100947
Mata JE, Bishop MR, Tarantolo SR, Angle CR, Swanson SA, Iversen PL. Evidence of Enhanced Iron Excretion During Systemic Phosphorothioate Oligodeoxynucleotide Treatment. Journal of Toxicology: Clinical Toxicology. 2000;38(4):383-7.
Refrences
Title Journal Journal Categories Citations Publication Date
10.1182/blood.V92.2.632 1998
10.1200/JCO.1996.14.4.1320 1996
Effects of Size and Sequence on the lontophoretic Delivery of Oligonucleotidest Journal of Pharmaceutical Sciences
  • Medicine: Therapeutics. Pharmacology
  • Science: Chemistry: General. Including alchemy
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
 28 1998
CpG motifs in bacterial DNA trigger direct B-cell activation Nature
  • Science: Science (General)
 2,480 1995
10.1007/978-3-642-58785-6_5